LifeMD, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $194.1M | $154.8M | $152.5M | $119.0M | $92.9M |
| Cost of revenue | $27.7M | $21.4M | $18.9M | $18.7M | $18.0M |
| Gross profit | $166.3M | $133.4M | $133.6M | $100.4M | $74.9M |
| Operating expenses | $174.0M | $153.8M | $148.1M | $143.8M | $129.2M |
| Operating income | -$7.7M | -$20.4M | -$14.5M | -$43.4M | -$54.3M |
| Interest expense | $1.4M | $2.2M | $2.6M | $1.3M | $3.0M |
| Pretax income | -$10.2M | -$22.6M | -$17.4M | -$44.7M | -$61.3M |
| Income tax expense | $45,721 | $598,000 | $428,000 | $360,700 | $7,700 |
| Net income | $14.4M | -$21.4M | -$20.6M | -$45.5M | -$60.9M |
| Balance Sheet | |||||
| Cash and equivalents | — | $35.0M | $33.1M | $4.0M | $41.3M |
| Current assets | $51.8M | $52.4M | $42.6M | $11.3M | $44.9M |
| Total assets | $70.4M | $76.1M | $58.5M | $25.7M | $49.9M |
| Current liabilities | $41.6M | $67.4M | $34.8M | $31.4M | $22.8M |
| Total liabilities | $47.3M | $83.7M | $52.9M | $33.0M | $24.1M |
| Stockholders' equity | $23.2M | -$9.1M | $3.5M | -$11.4M | $22.7M |
| Cash Flow Statement | |||||
| Cash from operations | $8.3M | $17.5M | $8.8M | -$22.9M | -$33.1M |
| Depreciation and amortization | $865,524 | $465,830 | $203,952 | $161,885 | $13,560 |
| Stock-based compensation | $10.5M | $12.2M | $12.5M | $13.7M | $12.1M |
| Capital expenditure | $1.9M | $1.5M | $203,814 | $366,633 | $247,365 |
| Free cash flow | $6.4M | $16.0M | $8.6M | -$23.3M | -$33.3M |
| Dividends paid | $3.1M | $3.1M | $3.1M | $3.1M | $871,476 |
| Share repurchases | $270,000 | — | — | — | — |
| Impairments | — | — | — | $8.9M | — |
Shares outstanding 48.4M · Free float 79.8%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.